Literature DB >> 15547761

PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.

María Mar Inda1, Javier Mercapide, Jorge Muñoz, Philippe Coullin, Giséle Danglot, Teresa Tuñon, José María Martínez-Peñuela, José María Rivera, Juan J Burgos, Alain Bernheim, Javier S Castresana.   

Abstract

Medulloblastoma, which accounts for 20-25% of all childhood brain tumors, is defined as a primitive neuroectodermal tumor (PNET) located in the cerebellum. Supratentorial PNET are less frequent than medulloblastoma. But their clinical outcome is worse than in medulloblastomas. Chromosome 10q contains at least 2 tumor suppressor genes that might play a role in brain tumor development: PTEN and DMBT1. The aim of this study was to compare the status of homozygous deletion and expression of PTEN and DMBT1 genes in PNET primary tumor samples and cell lines. Homozygous deletions of PTEN and DMBT1 were studied in 32 paraffin-embedded PNET samples (23 medulloblastomas and 9 supratentorial PNET) and in 7 PNET cell lines, by differential PCR and by FISH. PTEN homozygous losses were demonstrated in 7 medulloblastomas (32%) and in no supratentorial PNET, while homozygous deletions of DMBT1 appeared in 1 supratentorial PNET (20%) and in 7 medulloblastomas (33%). No homozygous deletion of PTEN or DMBT1 was detected in any of the PNET cell lines either by differential PCR or by FISH. Expression study of the 2 genes was performed in the 7 PNET cell lines by RT-PCR. One PNET cell line lacked PTEN and DMBT1 expression, while 2 medulloblastoma cell lines did not express DMBT1. Our results add some positive data to the hypothesis that supratentorial PNETs and medulloblastomas might be genetically different.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547761

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

Review 1.  Matching mice to malignancy: molecular subgroups and models of medulloblastoma.

Authors:  Jasmine Lau; Christin Schmidt; Shirley L Markant; Michael D Taylor; Robert J Wechsler-Reya; William A Weiss
Journal:  Childs Nerv Syst       Date:  2012-04       Impact factor: 1.475

2.  A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.

Authors:  Tara Spence; Christian Perotti; Patrick Sin-Chan; Daniel Picard; Wei Wu; Anjali Singh; Colleen Anderson; Michael D Blough; J Gregory Cairncross; Lucie Lafay-Cousin; Douglas Strother; Cynthia Hawkins; Aru Narendran; Annie Huang; Jennifer A Chan
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

Review 3.  Aggressive infantile embryonal tumors.

Authors:  Tobey J MacDonald
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

4.  PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.

Authors:  Alok R Singh; Shweta Joshi; Muamera Zulcic; Michael Alcaraz; Joseph R Garlich; Guillermo A Morales; Yoon J Cho; Lei Bao; Michael L Levy; Robert Newbury; Denise Malicki; Karen Messer; John Crawford; Donald L Durden
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.